Medy-Tox Inc. (KOSDAQ:086900)
South Korea flag South Korea · Delayed Price · Currency is KRW
108,600
+1,100 (1.02%)
Apr 29, 2026, 3:30 PM KST

Medy-Tox Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
48,89546,16833,24620,68871,777
Short-Term Investments
506,11298.913,00010,150
Trading Asset Securities
-7,235-2,520-
Cash & Short-Term Investments
48,94559,51533,34526,20881,927
Cash Growth
-17.76%78.48%27.23%-68.01%47.31%
Accounts Receivable
50,90653,88060,50844,99828,703
Other Receivables
6,6602,8896,1396,48512,057
Receivables
57,56656,81767,50253,30243,523
Inventory
43,06564,25959,61852,62032,971
Prepaid Expenses
2,1321,3922,8921,866966.57
Other Current Assets
3,6284,5852,8751,1381,571
Total Current Assets
155,337186,568166,232135,134160,959
Property, Plant & Equipment
199,541200,270205,262208,878205,531
Long-Term Investments
51,78275,703113,576155,410122,377
Goodwill
-8,136--808.49
Other Intangible Assets
4,8686,6634,7304,4124,689
Long-Term Deferred Tax Assets
40,67124,37217,97314,26718,187
Long-Term Deferred Charges
72,76057,23049,49022,0586,308
Other Long-Term Assets
55,54754,97453,00055,32458,766
Total Assets
581,757615,163611,623596,288577,698
Accounts Payable
1,8043,1163,7493,3904,028
Accrued Expenses
4,0925,2297,1189,3891,554
Short-Term Debt
54,62059,30661,07995,10364,964
Current Portion of Long-Term Debt
2,000-20,0005,01212,000
Current Portion of Leases
502.18731.95525.21411.35571.91
Current Income Taxes Payable
2,3774,8727,9827,99313,861
Current Unearned Revenue
----361.68
Other Current Liabilities
39,42238,43326,10313,96410,606
Total Current Liabilities
104,817111,688126,556135,262107,947
Long-Term Debt
18,00020,000-20,00055,057
Long-Term Leases
1,5081,2791,226335.95324.74
Long-Term Unearned Revenue
----1,296
Pension & Post-Retirement Benefits
150.69200.54130.74-941.74
Long-Term Deferred Tax Liabilities
-308.87229.31818.57505.65
Other Long-Term Liabilities
2,9955,0368,9986,2568,062
Total Liabilities
127,471138,513137,141162,673174,134
Common Stock
3,6493,6493,6493,3313,127
Additional Paid-In Capital
153,279148,053148,037112,896113,978
Retained Earnings
435,868425,211406,665401,111364,112
Treasury Stock
-119,978-106,887-96,921-106,229-89,296
Comprehensive Income & Other
-21,196-3,7707,81316,6937,288
Total Common Equity
451,622466,256469,242427,802399,208
Minority Interest
2,4444,3095,0205,5714,084
Shareholders' Equity
454,286476,649474,482433,616403,565
Total Liabilities & Equity
581,757615,163611,623596,288577,698
Total Debt
76,63081,31882,830120,862132,917
Net Cash (Debt)
-27,685-21,803-49,485-94,654-50,990
Net Cash Per Share
-4202.59-3242.53-7389.19-14418.99-7944.34
Filing Date Shares Outstanding
6.566.666.736.046.06
Total Common Shares Outstanding
6.566.666.736.346.36
Working Capital
50,52074,88039,676-128.3453,012
Book Value Per Share
68895.4470014.3669721.6467506.1262787.02
Tangible Book Value
446,754451,457464,512423,390393,711
Tangible Book Value Per Share
68152.8067792.1769018.8366809.9861922.46
Land
49,40349,51449,51449,51446,032
Buildings
93,92994,19894,12274,03973,053
Machinery
32,71629,68728,02126,10324,476
Construction In Progress
21,63913,60514,21871,94164,047
Source: S&P Global Market Intelligence. Standard template. Financial Sources.